Save to favorites
This feature is restricted to active members.
Join now to save favorites and get all member benefits, including over 1,400 reviews.
Join NowAlready a member? Sign in here.
Recalls & Warnings
ConsumerLab.com is keeping you informed with current product recalls and warnings.
Posted July 23, 2019
FDA Warns Seller of CBD Lotions, Patches, Tinctures and Pet Products
On July 22, 2019, the FDA issued a warning letter to Curaleaf, Inc., following an inspection of the company's website which found the company's products, including its CBD Lotion , CBD Pain-Relief Patch, CBD Tincture and Bido CBD for Pets to be "unapproved new and misbranded" drugs. The FDA noted that CBD cannot be sold as a dietary supplement. It also pointed to statements made about the products on the company's website and social media sites that it has determined are drug claims because they promote the products as preventing or treating diseases.
Join today to unlock all member benefits including full access to all recalls & warnings
Join NowAlready a member? Sign In Here.
Join now at www.consumerlab.com/join/
Report a Problem
If you have experienced an unexpected and adverse reaction to a dietary supplement, nutritional product, or generic drug, we would like to hear about it, as we may investigate the problem. Please select from one of these options:
Dietary Supplement or Nutritional Product Problem Report
If you believe that a dietary supplement (e.g., vitamin, mineral, or herbal supplement) or other nutritional product has caused an unexpected, adverse reaction, we would like to know about it. We are collecting and organizing this information and may publish it. We might test the product in the future. You may also want to report the problem to the U.S. FDA through their Safety Reporting Portal at https://www.safetyreporting.hhs.gov.
Please complete the form below as accurately as possible. You may need to check the label on the product.
Thank you for submitting your report.
Generic Drug Problem Report
If you believe that a generic drug has not acted like the original drug, we would like to know about it. We are collecting and organizing this information and may publish it. We might test the product in the future. You may also want to report the problem to the U.S. FDA through their MedWatch program at the FDA MedWatch website.
Please complete the form below as accurately as possible. You may need to check the label on the drug.
Thank you for submitting your report.
